Quest Diagnostics Shares Outstanding 2010-2025 | DGX
Quest Diagnostics shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Quest Diagnostics shares outstanding for the quarter ending March 31, 2025 were 113M, a 0.89% increase year-over-year.
- Quest Diagnostics 2024 shares outstanding were 0.113B, a 0% decline from 2023.
- Quest Diagnostics 2023 shares outstanding were 0.113B, a 4.24% decline from 2022.
- Quest Diagnostics 2022 shares outstanding were 0.118B, a 7.81% decline from 2021.
Quest Diagnostics Annual Shares Outstanding
(Millions of Shares) |
| 2024 |
113 |
| 2023 |
113 |
| 2022 |
118 |
| 2021 |
128 |
| 2020 |
136 |
| 2019 |
136 |
| 2018 |
139 |
| 2017 |
140 |
| 2016 |
142 |
| 2015 |
145 |
| 2014 |
145 |
| 2013 |
153 |
| 2012 |
160 |
| 2011 |
160 |
| 2010 |
177 |
| 2009 |
188 |
Quest Diagnostics Quarterly Shares Outstanding
(Millions of Shares) |
| 2025-03-31 |
113 |
| 2024-12-31 |
113 |
| 2024-09-30 |
113 |
| 2024-06-30 |
112 |
| 2024-03-31 |
112 |
| 2023-12-31 |
113 |
| 2023-09-30 |
114 |
| 2023-06-30 |
114 |
| 2023-03-31 |
113 |
| 2022-12-31 |
118 |
| 2022-09-30 |
118 |
| 2022-06-30 |
119 |
| 2022-03-31 |
121 |
| 2021-12-31 |
128 |
| 2021-09-30 |
125 |
| 2021-06-30 |
127 |
| 2021-03-31 |
135 |
| 2020-12-31 |
136 |
| 2020-09-30 |
137 |
| 2020-06-30 |
136 |
| 2020-03-31 |
135 |
| 2019-12-31 |
136 |
| 2019-09-30 |
137 |
| 2019-06-30 |
136 |
| 2019-03-31 |
136 |
| 2018-12-31 |
139 |
| 2018-09-30 |
139 |
| 2018-06-30 |
139 |
| 2018-03-31 |
139 |
| 2017-12-31 |
140 |
| 2017-09-30 |
140 |
| 2017-06-30 |
140 |
| 2017-03-31 |
141 |
| 2016-12-31 |
142 |
| 2016-09-30 |
142 |
| 2016-06-30 |
142 |
| 2016-03-31 |
144 |
| 2015-12-31 |
145 |
| 2015-09-30 |
145 |
| 2015-06-30 |
145 |
| 2015-03-31 |
146 |
| 2014-12-31 |
145 |
| 2014-09-30 |
145 |
| 2014-06-30 |
145 |
| 2014-03-31 |
145 |
| 2013-12-31 |
153 |
| 2013-09-30 |
151 |
| 2013-06-30 |
154 |
| 2013-03-31 |
159 |
| 2012-12-31 |
160 |
| 2012-09-30 |
161 |
| 2012-06-30 |
160 |
| 2012-03-31 |
160 |
| 2011-12-31 |
160 |
| 2011-09-30 |
159 |
| 2011-06-30 |
159 |
| 2011-03-31 |
161 |
| 2010-12-31 |
177 |
| 2010-09-30 |
174 |
| 2010-06-30 |
181 |
| 2010-03-31 |
182 |
| 2009-12-31 |
188 |
| 2009-09-30 |
187 |
| 2009-06-30 |
187 |
| 2009-03-31 |
191 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$19.115B |
$9.872B |
|
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
|
